Emergent Biosolutions INC Form 4 insider transactions

NYSE
EVP Jennifer Lynne Fox reports disposals of Emergent BioSolutions stock to cover tax obligations arising from equity compensation.
NYSE
Paul Anthony Williams, SVP, Products Business at Emergent BioSolutions Inc., reports the disposition of 105 shares of common stock to cover tax obligations on February 23, 2024.
NYSE
EVP Jennifer Lynne Fox reports disposition of Emergent BioSolutions shares to cover tax obligations.
NYSE
Richard Lindahl, EVP and CFO of Emergent BioSolutions, reports the disposition of shares due to performance stock unit vesting and tax withholding.